Jaguar Health Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue	9.76	11.96	4.34	9.39	5.78	4.42	4.36	0.14	0.26	0
Revenue Growth (YoY)	-18.36%	175.80%	-53.81%	62.51%	30.77%	1.26%	2981.61%	-45.23%	-	-
Cost of Revenue	2.04	2.02	2.33	3.28	3.82	2.77	0.88	0.05	0.12	0
Gross Profit	7.72	9.94	2	6.11	1.96	1.65	3.48	0.09	0.13	0
Selling, General & Admin	23.05	26.71	26	21	20.44	22.11	14.33	6.47	6.1	4.1
Research & Development	18.6	17.65	15.08	6.41	5.82	5.15	4.27	7.21	6.48	4.22
Other Operating Expenses	0.37	0	1.63	5.34	4.65	5.21	19.13	0	0	0
Operating Expenses	42.02	44.35	42.71	32.75	30.91	32.47	37.73	13.68	12.58	8.32
Operating Income	-34.29	-34.42	-40.71	-26.65	-28.95	-30.82	-34.25	-13.59	-12.45	-8.32
Interest Expense / Income	6.38	12.72	8.42	2.79	5.73	2.63	1.21	0.99	3.32	0.35
Other Expense / Income	0.63	0.32	3.47	4.37	3.85	-1.31	-0.31	0.16	0.53	-0.05
Pretax Income	-41.3	-47.45	-52.6	-33.81	-38.53	-32.15	-35.15	-14.73	-16.29	-8.61
Income Tax	0	0	0	0	0.01	0	-13.18	0	0	0
Net Income	-41.3	-47.45	-52.6	-33.81	-38.54	-32.15	-21.97	-14.73	-16.29	-8.61
Preferred Dividends	0	0	0	4.84	6.19	0	0	0	0.35	0.65
Net Income Common	-41.3	-47.45	-52.6	-38.65	-44.73	-32.15	-21.97	-14.73	-16.64	-9.26
Shares Outstanding (Basic)	23	1	1	0	0	0	0	0	0	0
Shares Outstanding (Diluted)	23	1	1	0	0	0	0	0	0	0
Shares Change	1658.91%	120.00%	247.12%	678.27%	2267.70%	406.52%	300.00%	76.92%	116.67%	-
EPS (Basic)	-1.79	-36.18	-88.22	-225.01	-2027.32	-34486.96	-119546.68	-318948.50	-637897.01	-765476.41
EPS (Diluted)	-1.79	-36.18	-88.22	-225.01	-2027.32	-34486.96	-119546.68	-318948.50	-637897.01	-765476.41
Free Cash Flow	-33.24	-33.18	-34.98	-15.29	-20.46	-22.74	-9.82	-14.52	-14.32	-5.41
Free Cash Flow Per Share	-1.44	-25.30	-58.67	-89.00	-927.02	-24393.79	-53440.27	-313203.57	-549783.56	-448134.99
Gross Margin	79.13%	83.11%	46.18%	65.05%	33.92%	37.37%	79.81%	63.28%	52.22%	-
Operating Margin	-351.31%	-287.85%	-939.05%	-283.93%	-501.26%	-697.98%	-785.27%	-9599.84%	-4816.67%	-
Profit Margin	-423.11%	-396.91%	-1213.26%	-411.81%	-774.48%	-727.92%	-503.73%	-10410.87%	-6439.30%	-
Free Cash Flow Margin	-340.56%	-277.53%	-806.83%	-162.87%	-354.23%	-514.87%	-225.28%	-10258.35%	-5541.65%	-
EBITDA	-32.53	-32.44	-42.36	-28.74	-30.87	-28.2	-33.36	-13.7	-12.97	-8.26
EBITDA Margin	-333.27%	-271.32%	-977.19%	-306.20%	-534.55%	-638.53%	-764.84%	-9680.93%	-5019.37%	-
Depreciation & Amortization	2.39	2.29	1.81	2.28	1.93	1.32	0.58	0.05	0.01	0
EBIT	-34.92	-34.73	-44.17	-31.02	-32.8	-29.52	-33.94	-13.75	-12.97	-8.26
EBIT Margin	-357.73%	-290.49%	-1019.01%	-330.50%	-567.93%	-668.40%	-778.23%	-9714.49%	-5021.37%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).